UA104822C2 - Способ, соединение, фармацевтическая композиция и лекарственное средство для восстановления утраченной памяти в норме и патологии - Google Patents
Способ, соединение, фармацевтическая композиция и лекарственное средство для восстановления утраченной памяти в норме и патологииInfo
- Publication number
- UA104822C2 UA104822C2 UAA201303657A UAA201303657A UA104822C2 UA 104822 C2 UA104822 C2 UA 104822C2 UA A201303657 A UAA201303657 A UA A201303657A UA A201303657 A UAA201303657 A UA A201303657A UA 104822 C2 UA104822 C2 UA 104822C2
- Authority
- UA
- Ukraine
- Prior art keywords
- pharmaceutical composition
- nitrogen
- general formula
- compounds
- body weight
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2010137094/04A RU2457205C2 (ru) | 2010-09-07 | 2010-09-07 | Способ, соединение и фармацевтическая композиция и лекарственное средство для восстановления утраченной памяти в норме и патологии |
| PCT/RU2011/000677 WO2012033435A1 (ru) | 2010-09-07 | 2011-09-06 | Способ, соединение, фармацевтическая композиция и лекарственное средство для восстановления утраченной памяти в норме и патологии |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA104822C2 true UA104822C2 (ru) | 2014-03-11 |
Family
ID=45810868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201303657A UA104822C2 (ru) | 2010-09-07 | 2011-09-06 | Способ, соединение, фармацевтическая композиция и лекарственное средство для восстановления утраченной памяти в норме и патологии |
Country Status (4)
| Country | Link |
|---|---|
| EA (1) | EA028534B1 (ru) |
| RU (1) | RU2457205C2 (ru) |
| UA (1) | UA104822C2 (ru) |
| WO (1) | WO2012033435A1 (ru) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2016146594A (ru) * | 2016-11-28 | 2018-05-28 | Общество С Ограниченной Ответственностью "Биофарм-Меморейн" | Средство для лечения деменции различной этиологии |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW449590B (en) * | 1995-04-14 | 2001-08-11 | Boehringer Ingelheim Kg | New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds |
| RU2364587C2 (ru) * | 2003-10-29 | 2009-08-20 | Элан Фармасьютикалз, Инк. | N-замещенные бензолсульфонамиды |
| CA2711995A1 (en) * | 2008-01-29 | 2009-08-06 | F. Hoffmann-La Roche Ag | Novel n-(2-amino-phenyl)-amide derivatives |
-
2010
- 2010-09-07 RU RU2010137094/04A patent/RU2457205C2/ru active IP Right Revival
-
2011
- 2011-09-06 WO PCT/RU2011/000677 patent/WO2012033435A1/ru active Application Filing
- 2011-09-06 EA EA201370026A patent/EA028534B1/ru not_active IP Right Cessation
- 2011-09-06 UA UAA201303657A patent/UA104822C2/ru unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA201370026A1 (ru) | 2013-07-30 |
| EA028534B1 (ru) | 2017-11-30 |
| RU2010137094A (ru) | 2012-04-20 |
| RU2457205C2 (ru) | 2012-07-27 |
| WO2012033435A1 (ru) | 2012-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA107112C2 (en) | Activator of soluble guanylate cyclase | |
| WO2007138472A3 (en) | Triazolopyridazine derivatives | |
| WO2009152189A8 (en) | Low dose topiramate/phentermine compostion and methods of use thereof | |
| BR112012009215A2 (pt) | "terapia combinada contra o cancer com compostos inibidores de hsp90" | |
| UA109698C2 (xx) | Похідні азаіндазолу або діазаіндазолу як медикамент | |
| BR112012027640A2 (pt) | composto, composição farmacêutica uso de um composto, e, métodos de preparar uma composição farmacêutica, de inibir a função da 11beta-hidroxiesteroide desidrogenase do tipo 1 e de tratamento ou prevenção de um distúrbio | |
| ITBO20110012A1 (it) | Composizioni farmaceutiche comprendenti rifaximina e loro uso. | |
| EA201100305A1 (ru) | Лечение респираторных заболеваний | |
| WO2008125600A3 (en) | Pyrazole derivatives as p2x7 modulators | |
| TW200626158A (en) | Naphthaline derivatives | |
| EA201070588A1 (ru) | Производные 1,2,3-триазола для применения в качестве ингибиторов стеароил-соа десатуразы | |
| MX2011008910A (es) | Derivados de azol sustituidos, composicion farmaceutica que comprende los derivados, y uso de los derivados para tratar enfermeda de parkinson. | |
| WO2009066041A3 (fr) | Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| UA97348C2 (en) | HETEROCYCLIC NF-kB INHIBITORS | |
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| BR112013026257A2 (pt) | derivados de glicosídeo e usos dos mesmos para o tratamento de diabetes | |
| BR112013017302A2 (pt) | formulações de imunossupressor | |
| AR076300A1 (es) | Derivados de pirimidin imidazoles sustituidos, inhibidores de gsk3, composiciones farmaceuticas que los contienen y usos de los mismos en el tratamiento del alzheimer, enfermedades neurodegenerativas agudas, diabetes y otras enfermedades. | |
| CO6361855A2 (es) | Derivados de 7-hidroxi-benzoimidazol-4-il-,etanona e inhibidores de cinasa que enlaza pdz que contienen los mismos | |
| MX2009006114A (es) | Composiciones que comprenden carisoprodol y metodos de uso de las mismas. | |
| BR112012022632A2 (pt) | Medicamento compreendendo agonista de ep4 | |
| CO6612211A2 (es) | Derivado de amida que tiene una acción hipoglucémica y/o una acción protectora de células b o pancreas | |
| UA104822C2 (ru) | Способ, соединение, фармацевтическая композиция и лекарственное средство для восстановления утраченной памяти в норме и патологии | |
| MA32719B1 (fr) | Formulations galeniques de composes organiques | |
| WO2010040862A3 (en) | New activators for treating and/or preventing diseases or medical conditions which benefit from an increased transport of hyaluronan across a lipid bilayer |